Compare ANGO & GEVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGO | GEVO |
|---|---|---|
| Founded | 1988 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Major Chemicals |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.2M | 468.8M |
| IPO Year | 2004 | 2010 |
| Metric | ANGO | GEVO |
|---|---|---|
| Price | $10.37 | $1.98 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $18.00 | $6.42 |
| AVG Volume (30 Days) | 496.7K | ★ 4.4M |
| Earning Date | 04-02-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 81.92 | 58.82 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $291,010,000.00 | $711,000.00 |
| Revenue This Year | $9.11 | $19.44 |
| Revenue Next Year | $4.94 | $5.59 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.17 | N/A |
| 52 Week Low | $8.36 | $1.00 |
| 52 Week High | $13.99 | $2.97 |
| Indicator | ANGO | GEVO |
|---|---|---|
| Relative Strength Index (RSI) | 47.35 | 41.07 |
| Support Level | $9.62 | $1.92 |
| Resistance Level | $11.06 | $2.19 |
| Average True Range (ATR) | 0.59 | 0.20 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 38.01 | 9.91 |
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
Gevo Inc is a growth-oriented company that focuses on hard to decarbonize market sectors such as jet fuel, certain specialty fuels, on-road fuels, chemicals and materials, and certain products for the food chain such as protein and feeds made as co-products from its processes. It produces and sells competitively priced, renewable, drop-in products for these sectors, and generate carbon abatement value through its plant design and business systems. It owns and operates an ethanol plant with an adjacent CCS facility, Class VI carbon-storage well, and others. The group is currently developing the world's first large-scale ATJ facility to be co-located at the North Dakota site.